tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CELU Stock Latest News

Celularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
Press ReleasesCelularity to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
14d ago
CELU
Celularity Announces Board Changes and New Indemnification Agreement
PremiumCompany Announcements
Celularity Announces Board Changes and New Indemnification Agreement
22d ago
8K
CELU
Celularity Appoints Richard J. Berman to its Board of Directors
PremiumPress Releases
Celularity Appoints Richard J. Berman to its Board of Directors
22d ago
CELU
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
PremiumPress Releases
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
27d ago
CELU
Celularity receives noncompliance notification from Nasdaq
PremiumThe Fly
Celularity receives noncompliance notification from Nasdaq
27d ago
CELU
Celularity Board Member Marc Mazur Announces Resignation
PremiumCompany AnnouncementsCelularity Board Member Marc Mazur Announces Resignation
2M ago
8K
CELU
Celularity sees Q2 net sales of biomaterial product, biobanking $11M-$13M
Premium
The Fly
Celularity sees Q2 net sales of biomaterial product, biobanking $11M-$13M
2M ago
CELU
Celularity sees Q1 net sales of biomaterial product, biobanking $14.8M
Premium
The Fly
Celularity sees Q1 net sales of biomaterial product, biobanking $14.8M
2M ago
CELU
Celularity reports Q4 combined net sales $12.1M
PremiumThe Fly
Celularity reports Q4 combined net sales $12.1M
2M ago
CELU
Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023
PremiumPress Releases
Celularity Reports Full Year 2023 Combined Net Sales of $22.8 Million, a 26.7% Increase Over Full Year 2022, and Announces First Half 2024 Expected Combined Net Sales of $26.9 Million Representing 290% Growth Over First Half 2023
2M ago
CELU
Celularity presents data from T-cell platform at ASCO Annual Meeting
PremiumThe Fly
Celularity presents data from T-cell platform at ASCO Annual Meeting
4M ago
CELU
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
4M ago
CELU
Celularity receives noncompliance notification from Nasdaq
PremiumThe FlyCelularity receives noncompliance notification from Nasdaq
4M ago
CELU
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
Premium
Press Releases
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
4M ago
CELU
Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy
Premium
Press Releases
Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy
4M ago
CELU
Celularity announces publication on benefits of placental circulating T cells
PremiumThe Fly
Celularity announces publication on benefits of placental circulating T cells
4M ago
CELU
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
PremiumPress Releases
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
5M ago
CELU
Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024
PremiumPress Releases
Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024
5M ago
CELU
Celularity Q1 sales are trending ahead of expectations
PremiumThe Fly
Celularity Q1 sales are trending ahead of expectations
5M ago
CELU
Celularity data showing senescent cell elimination to be presented at ASGCT
PremiumThe FlyCelularity data showing senescent cell elimination to be presented at ASGCT
5M ago
CELU
Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cells
Premium
Press Releases
Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells Derived from Human Placental Cells
5M ago
CELU
Celularity receives HCPCS Q code approval from U.S. CMS for Biovance 3L
Premium
The Fly
Celularity receives HCPCS Q code approval from U.S. CMS for Biovance 3L
6M ago
CELU

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >